B. Kohl

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[1',2':4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium salts and their reactions with thiols

J. Senn‐Bilfinger, U. Krueger, E. Sturm, 1987 .

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 3. Evidence for the involvement of a sulfenic acid in their reactions

J. Senn‐Bilfinger, U. Krueger, E. Sturm, 1990 .

The continuing development of proton pump inhibitors with particular reference to pantoprazole

G. Sachs, G. Sachs, W. Simon, 1995, Alimentary pharmacology & therapeutics.

Synthesis of Substituted Imidazo[1,2‐h][1,7]naphthyridines as H+/K+‐ATPase Inhibiting Drug Precursors via Directed ortho‐Metalation of Imidazo[1,2‐a]pyridines.

P. Zimmermann, J. Senn‐Bilfinger, B. Kohl, 2009 .

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 1. Their reaction with thiols under acidic conditions. Disulfide containing 2-pyridiniobenzimidazolides as mimics for the inhibited enzyme

J. Senn‐Bilfinger, U. Krueger, E. Sturm, 1987 .

(H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.

W. Simon, B Kohl, E Sturm, 1992, Journal of medicinal chemistry.

False-positive EMIT indication of opiates and methadone in a doxylamine intoxication.

H. von Boehmer, H. Wellhöner, E. Hausmann, 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Acid activation of (H+−K+)-ATPase inhibiting 2-(2-pyridylmethyl-sulphinyl)benzimidazoles: isolation and characterization of the thiophilic active principlë and its reactions

E. Sturm, V. Figala, K. Klemm, 1986 .